CIIRC Clinical Trials
Clinical trials are important research studies that evaluate the safety and effectiveness of new medications and therapies, such as vaccines. Clinical trials are also needed to assess whether an established therapy can be used for a different purpose or a different population. For example, the human papillomavirus (HPV) vaccine was first tested among females to prevent high-grade cervical lesions (cervical pre-cancer). A subsequent trial followed to determine if the HPV vaccine was also effective in preventing anogenital HPV-related diseases among males. Yet another trial assessed if the vaccine was also safe and effective for mid-adults. These trials are why the HPV vaccine is recommended for males and females ages 9-45.
Clinical trials may compare new, experimental treatments either to those which are in current clinical practice or to a placebo (inactive treatment) to scientifically study the value of new approaches. Whether the therapy is for cancer prevention or for treating cancer, clinical trials are vital for ensuring we provide the best care to our patients and community.
Interested in learning about CIIRC trials? You can search the clinical trials page with keywords, such as HPV, vaccine, injection, and hepatitis.
Center for Immunization and Infection Research in Cancer